Topics
Treatment, Biology / Mechanism, Outcomes / Survival, Prevention / Risk
Modality
Immunotherapy, Targeted therapy, Biomarker / Liquid biopsy, Imaging
Study type
Review / Meta-analysis
Abstract
Renal cell carcinoma (RCC) is an immunogenic tumor in which tumor-associated neutrophils (TANs) and neutrophil extracellular traps (NETs) represent a functionally important component of the tumor microenvironment. Recent studies have revealed pronounced phenotypic heterogeneity of RCC-infiltrating neutrophils, including interferon-responsive, immunosuppressive PMN-MDSC-like, pro-angiogenic, and NET-forming…
Authors
Olga V Kovaleva, Vasiliy V Sinyov, Madina A Rashidova, Olga S Malashenko +1
AI-generated summary
Tumor-associated neutrophils in renal cell carcinoma. reports: Renal cell carcinoma (RCC) is an immunogenic tumor in which tumor-associated neutrophils (TANs) and neutrophil extracellular traps (NETs) represent a functionally important component of the tumor microenvironment. Recent studies have revealed pronounced phenotypic heterogeneity of RCC-infiltrating neutrophils, including interferon-responsive, immunosuppressive PMN-MDSC-like, pro-angiogenic, and NET-forming subsets that cannot be adequately described by the classical N1/N2 model. Their polarization is shaped by ELR + CXC chemokines (CXCL1, CXCL8), cytokine signals, systemic inflammation, hypoxia driven by VHL/HIF pathways, and tumor-intrinsic oncogenic alterations such as PTEN loss, ERβ- and c-Myc-dependent programs, as well as epigenetic remodeling.
This summary may be inaccurate. Verify with the primary paper.
Primary source: PubMed.